Escolar Documentos
Profissional Documentos
Cultura Documentos
To
The National Stock Exchange of India Ltd.
Exchange Plaza,
Telangana, India.
Email: neuland@neulandlabs.com
www.neulandlabs.com
Series: EQ,
Dear Sirs,
Particulars
a) name of the
entity(ies) forming part
of the amalgamation/
merger, details in brief
Name of Entity
etc.;
(Rs.crores)
Balance
Ltd. ("NHSPL")
Neuland Pharma Research Pvt.
Turnover
Profit/
Sheet
Size
FY 16
41.34
2.39
(1.44)
37.73
49.66
4.93
41.24
0,36
(1.04)
Ltd. ("NPRPL")
(Loss)
FY 16
Ltd. ("NHSPL")
5.59
35.36
18.37
Ltd. ("NPRPL") \
NHSPL is the Holding Company of Neuland Laboratories Ltd. and
NPRPL is a subsidiary of the Holding Company (i.e., NH5PL), hence
Neuland Phamna Research Pvt.
b) whether the
transaction would fall
within related party
transactions? If yes,
whether the same is
done at "arms' length"
c) Area of business of
the entity(ies)
d) Rationale for
amalgamation/ merger
Registered Office: Sanali Info Park, 'A' Block, Ground Floor, 8-2-1 20/113, Road No. 2, Banjara Hills, H^derabad - 500034, Telangana, India. ! GIN No :L85195TG1984PLC004393
NEULAND
Particulars
Details
enhance value to its stakeholders. Innovation and R&D will drive
future and it is important to have R&D within NLL.
e) In case of cash
consideration - amount
or otherwise share
exchange ratio
f) Brief details of
change in shareholding
pattern (if any) of
listed entity
Yours faithfully,
For Neuland Laboratories Limited
Sarada Bhamidipati
Company Secretary
CC: BSE Ltd., Phlroze Jeejeebhoy Towers, 25th Floor, Dalal Street, Mumbai - 400 001